India to United States: Allopurinol Export Trade Route
India has recorded 835 verified shipments of Allopurinol exported to United States, representing a combined trade value of $243.3M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $291.4K USD. The leading Indian exporter is UNICHEM LABORATORIES LIMITED, which accounts for 49% of total export value with 335 shipments worth $118.9M USD. On the buying side, NA is the largest importer in United States with $98.2M USD in purchases. The top 3 suppliers — UNICHEM LABORATORIES LIMITED, INDOCO REMEDIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Allopurinol corridor is one of India's established pharmaceutical export routes, with 835 shipments documented worth a combined $243.3M USD. The route is dominated by UNICHEM LABORATORIES LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $291.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 35 days port-to-port. The route has recorded an annual growth rate of 14%, placing it at rank #34 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in United States include NA, UNICHEM PHARMACEUTICALS (USA) INC, UNICHEM PHARMACEUTICALS (USA) INC. and 25 others. NA is the single largest importer with 204 shipments valued at $98.2M USD.
